Publication date: Nov 10, 2023 In 2021, an estimated 4800 people developed rifampicin-resistant tuberculosis in Mozambique, 75% of which went undiagnosed. Detailed molecular data on rifampicin-resistant and multidrug-resistant (MDR) tuberculosis ... Read more

Publication date: Dec 01, 2023 Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a major threat to global health, with the emergence of multi-drug and extensively drug-resistant strains posing a ... Read more

Publication date: Oct 10, 2023 Kazakhstan ranks among the countries with the highest number of MDR-TB patients per 100,000 population worldwide. The successful transmission of local MDR strains of Mycobacterium ... Read more

Publication date: Sep 10, 2023 Antibiotics have played a crucial role in the reduction in the incidence of TB globally as evidenced by the fact that before the mid-20th century, ... Read more

Publication date: Nov 23, 2023 The prevalence of Mycobacterium avium complex-pulmonary disease (MAC-PD) has become a growing concern worldwide, and current treatments involving macrolides (clarithromycin or azithromycin), ethambutol, and ... Read more

Publication date: Nov 20, 2023 Both tuberculosis (TB) and diabetes mellitus (DM) are major public health problems threatening global health. TB patients with DM have a higher bacterial burden and ... Read more

Publication date: Sep 26, 2023 The World Health Organization identifies tuberculosis (TB), caused by Mycobacterium tuberculosis, as a leading infectious killer. Although conventional treatments for TB exist, they come with ... Read more

Publication date: Nov 13, 2023 Whole genome sequencing (WGS) can identify clusters, transmission patterns and drug resistance mutations. This is important in low-burden settings such as Australia, as it can ... Read more

Publication date: Nov 09, 2023 In an effort to support the global fight against tuberculosis (TB), which is widely recognized as the most lethal infectious disease worldwide, we present the ... Read more